Domov › Rak trebušne slinavke › North Carolina › Durham
Klinične študije za Rak trebušne slinavke v Durham, NC
24 študij za Rak trebušne slinavke išče udeležence na lokacijah v Durham in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
The Vanguard Study: Testing a New Way to Screen for Cancer
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
A Study of PHN-012 in Patients With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- PHN-012-001 Site, Durham
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
Vključevanje udeležencevFaza 3
- Duke Cancer Center, Durham
DESTINY-PANTUMOUR04
Vključevanje udeležencevOpazovalna študija
- Research Site, Durham
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Vključevanje udeležencevFaza 2/3
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi stran
- University of North Carolina Hospitals at Hillsborough, Hillsborough · 13 mi stran
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Vključevanje udeležencevFaza 3
- Duke Cancer Center, Durham
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Vključevanje udeležencevFaza 3
- Investigative Site US035, Chapel Hill · 10 mi stran
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Vključevanje udeležencevFaza 1/2
- Duke University Medical Center, Durham
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Vključevanje udeležencevFaza 2
- Local Institution - 0100, Durham
Promoting CT Engagement for Pancreatic Cancer With App
Vključevanje udeležencev
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Vključevanje udeležencevOpazovalna študija
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
- University of North Carolina-Hillsborough Campus, Hillsborough · 13 mi stran
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Vključevanje udeležencevFaza 2
- University of North Carolina, Chapel Hill · 10 mi stran
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Vključevanje udeležencevFaza 1
- University of North Carolina - Gastroenterology and Hepatology, Chapel Hill · 10 mi stran
- University of North Carolina, Chapel Hill · 10 mi stran
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Vključevanje udeležencevFaza 3
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Vključevanje udeležencevFaza 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Vključevanje udeležencevFaza 2
- Duke University Medical Center, Durham
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Vključevanje udeležencevFaza 1
- Duke Cancer Institute /ID# 276267, Durham
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Vključevanje udeležencevFaza 1
- Research Site, Durham
Autologous CAR-T Cells Targeting B7-H3 in PDAC
Vključevanje udeležencevFaza 1
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Vključevanje udeležencevFaza 1
- Duke Cancer Center, Durham
Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
Vključevanje udeležencevFaza 1/2
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
Vključevanje udeležencevFaza 2
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi stran
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Vključevanje udeležencevFaza 2
- University of North Carolina, Chapel Hill · 10 mi stran
Študije za Rak trebušne slinavke v drugih mestih
- Houston, TX61 študij
- New York City, NY60 študij
- Boston, MA43 študij
- Nashville, TN39 študij
- Los Angeles, CA35 študij
- St. Louis, MO33 študij
- Arlington, VA33 študij
- Baltimore, MD31 študij
- San Antonio, TX31 študij
- Philadelphia, PA26 študij
- Tampa, FL26 študij
- San Diego, CA24 študij
Druge študije v Durham
- Rak dojke64 študij
- Rak (vse vrste)58 študij
- Nemalicelični pljučni rak39 študij
- Množni mielom37 študij
- Akutna mieločna levkemija33 študij
- Metastatski rak33 študij
- Rak prostate32 študij
- Rak pljuč32 študij
- Kolorektalni rak28 študij
- Rak jajčnikov27 študij
- Kronična limfocitna levkemija27 študij
- Srčno popuščanje26 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.